University of Liverpool

Diseases, Conditions, Syndromes

Key inflammatory markers identified in COVID-19

A new study involving the University of Liverpool has identified new biomarkers of inflammation that both indicate the severity of COVID-19 and distinguish it from severe influenza.

Medications

Heparin targets coronavirus spike protein, research shows

An international team of researchers led by the Universities of Liverpool and Keele, working with Public Health England, has found that the common anticoagulant drug heparin inhibits the SARS-Cov2 virus spike protein, by ...

Diseases, Conditions, Syndromes

Antibody highs and lows in survivors of Ebola

A high proportion of survivors of Ebola experienced a resurgence in antibody levels nearly a year after recovery, a new University of Liverpool study has found.

page 11 from 40